medRxiv

Impact and cost-effectiveness of the 6-month BPaLM regimen for rifampicin-resistant tuberculosis: a mathematical modeling analysis medrxiv.org/content/10.1101/20

· · medRxiv article feed · 0 · 0 · 0
Sign in to participate in the conversation
CleverLibre Social

CleverLibre Social is an inclusive social instance for open discussion, learning, and community.
All cultures welcome.
Hate speech and harassment strictly forbidden.

Trending now

Resources

Developers

What is Mastodon?

social.cleverlibre.org

More…

v3.5.19-qoto · Privacy policy